Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations

National Medical Journal of China

Volumn 90, Issue 20, 2010, Pages 1416-1420

  Shen, Xiu Yun ^a   Shi, Rui Hua ^a   Wang, Ying ^a   Zhang, Hong Jie ^a   Zhou, Xi Qiao ^a   Shen, Fang Cheng ^a   Li, Ke Bei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Colitis, ulcerative; Crohn disease; Meta analysis; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; CHINESE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS; PHENOTYPE; ULCERATIVE COLITIS; ADOLESCENT; ADULT; AGED; ALLELE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84871462682     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.20.014     Document Type: Article

References (22)

1. Franchimont D, Vermeire S, El Housni H, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's and ulcerative colitis. Gut, 2004, 53:987-992.
2. Cario E, Podolsky D K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infct Immun, 2000, 68:7010-7017.
3. Szebeni B, Veres G, Dezsõfi A, et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immun, 2008, 151:34-41.
4. Török H P, Glas J, Tonenchi L, et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immun, 2004, 112:85-91.
5. Browning B L, Huebner C, Petermann I, et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol, 2007, 102:2504-2512.
6. Hong J, Leung E, Fraser A G, et al. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol, 2007, 22:1760-1766.
7. 2007, 27:545-550.
8. Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, et al. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Human Immunology, 2009, 70:121-124.
9. Baumgart D C, Büning C, Geerdts L, et al. The c.1-260C > T promoter variant of CD14 but not the c. 896A > G (p. D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion, 2007, 76:196-202.
10. Oostenbrug L E, Drenth J P H, De Jong D J, et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis, 2005, 11:567-575.
11. Brand S, Staudinger T, Schnitzler F, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis, 2005, 11:645-652.
12. Lakatos P L, Lakatos L, Szalay F, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol, 2005, 11:1489-1495.
13. Arnott I D, Nimmo E R, Drummond H E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients; evidence for genetic heterogeneity within Europe? Genes Immun, 2004, 5:417-425.
14. Braat H, Stokkers P, Hommes T, et al. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med, 2005, 83:601-609.
15. Ouburg S, Mallant-Hent R, Crusius J B A, et al. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut, 2005, 54: 439-440.
16. De Ridder L, Weersma R K, Dijkstra G, et al. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis, 2007, 13:1083-1092.
17. Fries W, Renda M C, Maria A, et al. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol, 2005, 100:2730-2736.
18. Rigoli L, Romano C, Caruso R A, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol, 2008, 14:4454-4461.
19. Hume G E, Fowler E V, Doecke J, et al. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflamm Bowel Dis, 2008, 14:585-590.
20. De Jager P L, Franchimont D, Waliszewska A, et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun, 2007, 8:387-397.
21. Xavier R J, Podolsky D K. Unraveling the pathogenesis of inflammatory bowel disease. Nature, 2007, 448: 427-434.
22. 2006, 14:212-215.